CFDE Data Portal | Search IFNAR2

	Label	Description
	IFNAR2 Gene (Entity type)	ENSG00000159110 - interferon alpha and beta receptor subunit 2
	IFNAR2 associations Collection (Entity type)	Associations for IFNAR2_associations
	IFNAR2 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GSE186471 1 V 2 CARNOSOL HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE101239 5 V 6 VALPROIC ACID MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE164874 5 V 10 PREDNISOLONE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE120210 GSE120214 TBXT brachyury inhibition 4 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE120612 7 V 5 ETOPOSIDE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE146982 metformin 4 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	IFNAR2-IL10RB Gene (Entity type)	ENSG00000249624 - IFNAR2-IL10RB readthrough

IFNAR2

ENSG00000159110 - interferon alpha and beta receptor subunit 2

IFNAR2 associations

Associations for IFNAR2_associations

IFNAR2 associations.tsv

A file from IDG as part of the Harmonizome project

GSE186471 1 V 2 CARNOSOL HUMAN DN

A Gene Set from LINCS

GSE101239 5 V 6 VALPROIC ACID MOUSE UP

A Gene Set from LINCS

GSE164874 5 V 10 PREDNISOLONE HUMAN DN

A Gene Set from LINCS

GSE120210 GSE120214 TBXT brachyury inhibition 4 v 0 human dn

A Gene Set from LINCS

GSE120612 7 V 5 ETOPOSIDE HUMAN UP

A Gene Set from LINCS

GSE146982 metformin 4 v 2 human up

A Gene Set from LINCS

IFNAR2-IL10RB

ENSG00000249624 - IFNAR2-IL10RB readthrough

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.